by MM360 Staff | Apr 17, 2025 | Uncategorized
Source: CureToday articles Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, replacing single-agent treatments. Read More
by MM360 Staff | Apr 17, 2025 | Uncategorized
Source: CureToday articles Experts at Hackensack Meridian Jersey Shore University Medical Center have successfully treated their first patients using the TAMP™ therapy platform. Read More
by MM360 Staff | Apr 17, 2025 | Uncategorized
Source: CureToday articles I stay in the cancer social media world because it helps me cope, even when friends disappear and I’m left wondering if they’re resting, retreating or gone. Read More
by MM360 Staff | Apr 17, 2025 | Uncategorized
Source: CureToday articles U.S. medical centers are seeking FDA authorization for the compassionate use — or expanded access — of Namodenoson for patients with pancreatic cancer. Read More
by MM360 Staff | Apr 17, 2025 | Uncategorized
Source: CureToday articles Emactuzumab has received fast track designation from the U.S. FDA for patients with tenosynovial giant cell tumors and who would not benefit from surgery. Read More
by MM360 Staff | Apr 17, 2025 | Uncategorized
Source: CureToday articles Patients with gastrointestinal cancer may benefit from multidisciplinary care and open communication with their care team, as per an expert. Read More
